- Report
- March 2025
- 187 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2024
- 30 Pages
Global
From €2611EUR$2,750USD£2,202GBP
- Report
- March 2025
- 50 Pages
Global
From €2516EUR$2,650USD£2,122GBP
Chenodeoxycholic acid (CDCA) is a bile acid used in the treatment of liver and kidney disorders. It is a naturally occurring bile acid found in the human body, and is also available as a synthetic drug. CDCA is used to treat a variety of liver and kidney disorders, including primary biliary cirrhosis, primary sclerosing cholangitis, and gallstones. It is also used to treat certain types of kidney stones. CDCA works by increasing bile flow, which helps to reduce the risk of gallstones and other bile-related disorders.
CDCA is available in both oral and injectable forms. Oral CDCA is typically taken once or twice daily, while injectable CDCA is administered intravenously. Common side effects of CDCA include nausea, vomiting, and abdominal pain.
The CDCA market is highly competitive, with several major pharmaceutical companies offering CDCA products. These include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more